ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1710

Major Vault Protein Contributes to Increased Interstitial Fibrosis in a Murine Model of CKD

Session Information

Category: Glomerular Diseases

  • 1201 Glomerular Diseases: Fibrosis and Extracellular Matrix

Authors

  • Wong, Cheuk Yin, The University of Hong Kong, Hong Kong, Hong Kong
  • Yung, Susan, The University of Hong Kong, Hong Kong, Hong Kong
  • Chan, Caleb C-Y, The University of Hong Kong, Hong Kong, Hong Kong
  • Chan, Tak Mao Daniel, The University of Hong Kong, Hong Kong, Hong Kong
Background

Chronic kidney disease (CKD) is a global health issue characterized by interstitial fibrosis and tubular atrophy, and progressive CKD results in kidney failure. There is currently no effective intervention for interstitial fibrosis. We previously showed that major vault protein (MVP), a key component of the vault complex, contributed to increased matrix protein deposition in murine unilateral ureteral obstruction (UUO) animal model. We extended our investigations to a murine model of CKD.

Methods

CKD was induced in MVP wild-type (WT) and knockout (KO) mice by feeding with standard chow containing 0.2% adenine for 8 weeks, after which time mice were sacrificed and kidneys were harvested and examined. Spot urine albumin-to-creatinine ratio was also measured. MVP WT and KO mice fed with standard chow served as controls.

Results

MVP WT mice with CKD showed increased MVP expression, predominantly in proximal tubular epithelial cells, compared to MVP WT control mice, and this was accompanied by development of proteinuria, tubular atrophy, tubulo-interstitial macrophage infiltration, and increased interstitial α-smooth muscle actin, fibronectin and collagen III expression. MVP KO mice with CKD showed less proteinuria (P<0.05) and less severe kidney histopathological features with reduced immune cell infiltration, and also reduced expression of fibrosis mediators compared to WT CKD mice. Exogenous TNF-α, IL-6, or MCP-1 increased MVP expression in cultured renal proximal tubular epithelial cells.

Conclusion

The data suggest that progressive CKD in this murine model is accompanied by increased renal tubular epithelial MVP expression, and MVP may contribute to the pathogenesis of tubulo-interstitial injury and damage.

Funding

  • Government Support - Non-U.S.